Litigation Details for Taiho Pharmaceutical Co., Ltd. v. MSN Laboratories Private Ltd. (D. Del. 2019)
✉ Email this page to a colleague
Taiho Pharmaceutical Co., Ltd. v. MSN Laboratories Private Ltd. (D. Del. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-12-23 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Jennifer L. Hall |
| Jury Demand | None | Referred To | |
| Patents | 10,456,399; 10,457,666; 9,527,833; RE46,284 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Taiho Pharmaceutical Co., Ltd. v. MSN Laboratories Private Ltd.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Taiho Pharmaceutical Co., Ltd. v. MSN Laboratories Private Ltd. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2022-03-25 | 106 | Redacted Document | claim for infringement of U.S. Patent No. 10,457,666 (“the ‘666 patent”). NATURE AND … In this patent infringement case, Taiho accuses MSN of infringing several patents by filing its…214024. (D.I. 1, 18.). One of these patents is the ‘666 patent, which claims a specific polymorphic…REGARDING INFRINGEMENT OF THE ‘666 PATENT BY MSN’S ANDA PRODUCT OF COUNSEL: …Allan Myerson (“Dr. Myerson”) concerning the ‘666 patent at trial. SUMMARY OF THE | External link to document |
| 2020-03-16 | 19 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,456,399 B2 ;10,457,666 B2.…23 December 2019 1:19-cv-02342 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2019-12-23 | 4 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE46,284 E; 9,527,833 B2. (kmd) (Entered…23 December 2019 1:19-cv-02342 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2021-07-22 | 73 | , M.D. Concerning the Invalidity of U.S. Patent No. RE46,284 filed by Natco Pharma Ltd., Natco Pharma,…23 December 2019 1:19-cv-02342 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
